1.
Gancitano G, Ravasio R, Dionisi M, Cortinovis D. Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer. FE [Internet]. 2018 May 23 [cited 2025 Jul. 23];19(1). Available from: https://provafe.seedstm.com/index.php/FE/article/view/1354